Skip to main content

Table 1 Modelled management costs and utility decrements

From: Long-term cost-effectiveness of quality of diabetes care; experiences from private and public diabetes centers in Iran

Year

1

≥ 2

Condition

public

private

Utility decrement

Annual cost (US$)

Utility decrement

Annual cost (US$)

Acute

Annual cost (US$)

Not acute

Annual cost (US$)

Acute

Annual cost (US$)

Not acute

Ischemic artery disease

616.87

1280.15

1603.862

3328.39

−0.010

338.81

0.000

Myocardial infarction

2018.98

2609.39

5249.348

6914.41

−0.148

527.14

−0.060

Heart failure

-

2577.25

-

6700.85

−0.071

1288.63

−0.185

Stroke

743.07

1650.99

1900

4292.5

−0.165

430.44

−0.165

Amputation

-

1363.57

100

3548

−0.200

368.53

−0.172

Blindness

-

434.91

-

1130.76

0.131

144.97

−0.103

End-stage renal disease

-

2886.87

-

7505.86

−0.330

1934.49

−0.330

Diabetic wound

-

907.31

-

1900

−0.200

193.04

−0.210